DESPITE the great effort on cancer research our progress towards an understanding of today's major medical problem continues to be disappointingly slow. It seems beholden on all to try to offer helpful contributions on possible mechanisms of carcinogenesis in the hope that a true understanding will more rapidly emerge. It is in this spirit that I suggest a mechanism for chemical carcinogenesis which is simple in essence but appears to have been ignored.
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Studies on cocarcinogenesis have established that the single application to skin of one chemical (the initiator) followed, after a suitable delay, by the repeated application of another (the promoter) can induce papillomas and more rarely carcinomas on the treated area. Neither the initiator nor the promoter need necessarily be detectably carcinogenic when acting alone. In explanation of these observations I propose that the initiator induces recessive mutations in genes controlling division in epithelial cells and that the promoter leads to homozygosity of the mutant genes and consequently to their expression. Let us examine this proposal.
It is reasonable to assume that the regulation of growth, division and differentiation of the mammalian cell is determined by its genetic complement; the zygote must contain complete information to programme all cell divisions and progression to the adult animal. We would expect this information to be coded in DNA and can therefore presume that there are genes concerned with the regulation of cell division. It is also reasonable to think that different genes exert their control at different stages during development and that mutations could result in altered gene products which no longer act correctly in regulating cell division. At present we have no idea how such regulation is effected at the molecular level in mammalian cells and are only now at the beginning of such studies with bacteria. Essentially cancers are manifestations of alterations of the normal controls of cell division and, on the above assumptions, could result from mutations of the relevant genes. That cancer cells differ genetically from their progenitors seems beyond question; they retain their characteristics over many cell generations, when transferred to new cellular environments as metastases and when transplanted to new permissive hosts.
A first requirement of the proposal is that initiators must be mutagenic in mammalian cells-are they? A problem here is that data concerning initiation derives mainly from studies on mammalian (usually mouse) skin whereas that for mutagenesis comes mainly from studies on micro-organisms. There is not complete correspondence of the two activities; however, the association between initiating and mutagenic activities is high, although the reverse is by no means so-many mutagens fail to act as initiators. Such mutagens may be metabolised or fail to reach potential targets in the tissue systems employed to detect initiating activity while having free access to their targets in microbial systems: they may therefore not conflict with the proposal. The rarer examples of chemicals with initiating but no demonstrable mutagenic action are of more concern but similar excuses could be invoked to account for them. The generality nevertheless is that initiators tend strongly to be mutagens as is required by the proposal.
It is not a prerequisite that cells must be in an actively dividing stage for sensitivity to chemical mutagenesis, so that a single application of the mutagen in adequate amount and at any time could suffice to induce the proposed mutations, as is found to be effective for initiation in practice. The majority of newly arising mutations in diploid cells are recessive to their wild-type alleles and mutations restricted to specific genes are rare events. One would expect, therefore, that initiators applied to an area of skin would, if acting as proposed, generate rare recessive mutant genes in cells composing the tissue; it is found that only a small fraction of the population of cells treated with the initiator eventually becomes cancerous. Simultaneous mutation of homologous gene pairs within a single diploid cell with retention of cell viability would be extremely rare (the product of the low separate probabilities) but, theoretically, would lead to undelayed expression of the mutations. Here we should bear in mind, in considering carcinogenesis in general, the very large population of cells forming the adult mammal (c. 1014 in man) which permits the extreme rarity of an event leading to a progressive cancer still to have real significance to the individual.
Cells which have acquired a recessive mutation in a gene normally concerned with control of some aspect of cell division, could reasonably be expected to divide at the rate normal for neighbouring cells composing the same tissue and so to persist indefinitely as part of the cell population. A gene dosage effect may, in fact, allow them to form an increasing proportion of this population with the passage of time. While such cells remained heterozygous they would not be extraordinary and would remain undetected; but should they become homozygous for the recessive character and relieved of the control exerted by the normal gene their unrestrained division might ensue to give a neoplasm. The production of recessive mutations as the primary event in chemical carcinogenesis clearly would explain the often long protracted time lag between the event and the appearance of the cancer. There are many ways in which homozygosity could be achieved; some obvious ones are loss of the normal allele by deletion, or of the chromosome carrying it through errors in mitosis such as non-disjunction of sister chromatids, interference with centromere structure or with spindle function, and by mitotic recombination. Natural examples of mis-divisions are seen in the production of trisomic individuals and of polyploid cells in plants and mammalian embryos. I propose that promoting chemicals increase the frequency of misdivision in some way to give homozygosity and consequent expression of the recessive mutations induced by the initiator.
If the promoter acts to cause errors during division one would expect its activity to be restricted to cells which are in, or are about to enter into, division, or even to those in a particular stage of the mitotic process, so that the observed requirement for the repeated application of the promoting substance would be understandable. The persistence of promoters applied to the skin may be short relative to the generation time of normal skin cells and of those carrying the recessive mutations of importance, so that to assure the coincidence ofan effective concentration of promoter and of cells in a sensitive stage of mitosis would require repeated application of the promoter for long periods. High levels of promoter acting for a short period would be less effective than lower, but adequate, levels acting for longer as is observed.
Assuming that promoters act by interference with chromosome distribution during cell division (which could be readily tested by experiment) the variety of cell types resulting, with respect to the mutations postulated to have arisen from the activity of the initiator, could be as follows:
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